Trophos

Trophos

Verified
Roche - Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need.

Launch date
Market cap
-
Net debt
-
Enterprise valuation
$546m (Public information from Jan 2015)
Marseille Provence-Alpes-Côte d'Azur (HQ)
  • Edit
Get premium to view all results
DateInvestorsAmountRound
-investor

$0.0

round
investor investor investor investor

$0.0

round

$546m

Valuation: $546m

Acquisition
Total Funding000k

Recent News about Trophos

Edit